Carcinogenicity of lipid-lowering drugs.
Tobert
J A
JA
D000214:Acyl Coenzyme A / Q000037:antagonists & inhibitors; D017277:Drug Approval; D004791:Enzyme Inhibitors / Q000009:adverse effects*; D006801:Humans; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D008099:Liver / Q000187:drug effects; D008113:Liver Neoplasms / Q000139:chemically induced*; D014481:United States; D014486:United States Food and Drug Administration
D000214:Acyl Coenzyme A; D004791:Enzyme Inhibitors; D000960:Hypolipidemic Agents; C008047:3-hydroxy-3-methylglutaryl-coenzyme A